Cargando…
Leukotriene Antagonists in Dermatology
Leukotriene antagonists constitute an important group of drugs in the therapeutic armamentarium of all dermatologists. It has been quite valuable in the management of various types of urticaria and atopic dermatitis. Recently, the role of zileuton in the management of acne has been elaborated, and i...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751694/ https://www.ncbi.nlm.nih.gov/pubmed/35068536 http://dx.doi.org/10.4103/ijd.IJD_557_18 |
_version_ | 1784631730842370048 |
---|---|
author | Bubna, Aditya Kumar |
author_facet | Bubna, Aditya Kumar |
author_sort | Bubna, Aditya Kumar |
collection | PubMed |
description | Leukotriene antagonists constitute an important group of drugs in the therapeutic armamentarium of all dermatologists. It has been quite valuable in the management of various types of urticaria and atopic dermatitis. Recently, the role of zileuton in the management of acne has been elaborated, and in the near future it could be used as a first-line agent for the same, thereby preventing adverse effects and antibiotic resistance encountered following antibiotic use. This review will throw light on the dermatologic aspects of leukotriene antagonists. |
format | Online Article Text |
id | pubmed-8751694 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-87516942022-01-21 Leukotriene Antagonists in Dermatology Bubna, Aditya Kumar Indian J Dermatol Resident's Page Leukotriene antagonists constitute an important group of drugs in the therapeutic armamentarium of all dermatologists. It has been quite valuable in the management of various types of urticaria and atopic dermatitis. Recently, the role of zileuton in the management of acne has been elaborated, and in the near future it could be used as a first-line agent for the same, thereby preventing adverse effects and antibiotic resistance encountered following antibiotic use. This review will throw light on the dermatologic aspects of leukotriene antagonists. Wolters Kluwer - Medknow 2021 /pmc/articles/PMC8751694/ /pubmed/35068536 http://dx.doi.org/10.4103/ijd.IJD_557_18 Text en Copyright: © 2021 Indian Journal of Dermatology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Resident's Page Bubna, Aditya Kumar Leukotriene Antagonists in Dermatology |
title | Leukotriene Antagonists in Dermatology |
title_full | Leukotriene Antagonists in Dermatology |
title_fullStr | Leukotriene Antagonists in Dermatology |
title_full_unstemmed | Leukotriene Antagonists in Dermatology |
title_short | Leukotriene Antagonists in Dermatology |
title_sort | leukotriene antagonists in dermatology |
topic | Resident's Page |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8751694/ https://www.ncbi.nlm.nih.gov/pubmed/35068536 http://dx.doi.org/10.4103/ijd.IJD_557_18 |
work_keys_str_mv | AT bubnaadityakumar leukotrieneantagonistsindermatology |